Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

UUroGen Pharma Ltd.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
U

UroGen Pharma Ltd.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

Loading earnings…

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
YearRevenue YoYGross marginCash & equivalents
YearRevenue YoYGross marginCash & equivalents
(Filed on March 2, 2026)
+21.4%88.7%$110.7M

An annual SEC report is unavailable for this year.

(Filed on March 2, 2026)
+9.3%90.2%$172M
(Filed on March 10, 2025)
+28.5%88.7%$95M
(Filed on March 14, 2024)
+34.0%88.1%$55.4M
(Filed on March 24, 2023)
+307.2%89.3%$44.4M
(Filed on March 21, 2022)
+65,450.0%91.4%$52.9M
(Filed on March 18, 2021)
-98.4%100.0%$49.7M
(Filed on March 2, 2020)
-86.2%-59.8%$101.3M
(Filed on March 2, 2020)
-53.5%92.6%$37M
(Filed on February 28, 2019)
—99.8%$21.4M
(Filed on March 15, 2018)
———